📰 Genevant Sciences News
Page 9 - Genevant Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genevant Sciences. Real-time updates on events, politics, business and more.
May 13, 2022
Peru adopts EPO system; Moderna says sue government; Appian awarded $2bn in trade secrets case; US senator threatens Disney copyright; Vidal announces examiner training; USPTO reveals pro bono awards
May 7, 2022
Moderna (MRNA) filed a motion to dismiss a lawsuit filed by two small biopharma companies seeking damages for violation of certain U.S
April 24, 2022
CytRx (NASDAQ:CYTR – Get Rating) and Gritstone bio (NASDAQ:GRTS – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, valuation, earnings and profitability. Profitability This table compares CytRx and Gritstone bio’s net margins, […]
March 21, 2022
The biotech company that makes mRNA-delivery technology for Pfizers COVID-19 vaccine sued Arbutus Biopharma in Manhattan federal court on Friday, seeking to head off claims that the vaccine infringes Arbutus patents.
March 18, 2022
It's a phull-on pharma phight. Lawsuits broke out Thursday over the underlying technology in two of the world's best Covid-19 vaccines. US...
March 18, 2022
By Blake Brittain (Reuters) - The biotech company that makes mRNA-delivery technology for Pfizer's COVID-19 vaccine sued Arbutus Biopharma Corp in Man...
March 18, 2022
The Canadian biotech company that makes mRNA-delivery technology for Pfizers COVID-19 vaccine sued Arbutus Biopharma in U.S. federal court, seeking to head off claims that the vaccine infringes Arbutus patents.
March 17, 2022
The latest coronavirus news from Canada and around the world Thursday. This file will be updated throughout the day. Web links to longer stories if available.
March 17, 2022
The two top manufacturers of COVID-19 vaccines in the U.S. are facing a lawsuit alleging they infringed another companys copyright in the development of their vaccines.